Skip to main content

Table 1 Demographics of patients

From: Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages

Characteristic

No. (%)

Gender

 Male

96 (54.2)

 Female

81 (45.8)

Age

  < 55 years

38 (21.5)

 55–65 years

55 (31.1)

 65.1–75 years

57 (32.2)

 75.1–90

27 (15.2)

BMI

 Underweight (<18.5)

12 (6.8)

 Normal (18.5 < =BMI < 25)

74 (41.8)

 Overweight (25 < =BMI < 30)

57 (32.2)

 Obese (> = 30)

34 (19.2)

Smoking history

 Current/recenta

52 (29.4)

 Former

81 (45.8)

 Never

44 (24.8)

Race

 White or Caucasian

148 (83.6)

 Black or African American

24 (13.6)

 Asian

2 (1.1)

 Other

3 (1.7)

Stage

 Stage I

13 (7.4)

 Stage II

12 (6.8)

 Stage III

28 (15.8)

 Stage IV

122 (68.9)

 Unknown

2 (1.1)

# of metastasis sites

 0

85 (48.0)

 1

64 (36.2)

 2

18 (10.2)

  ≥ 3

10 (5.6)

Vital status

 Alive

118 (66.7)

 Dead

59 (33.3)

Tumor type

 Lung adenocarcinoma

52 (29.4)

 Non-small cell lung cancer-not otherwise specified

24 (13.5)

 Lung squamous carcinoma

21 (11.9)

 Head/Neck

16 (9.0)

 Colorectal

12 (6.8)

 Cancer of unknown primary (CUP)

12 (6.8)

 Other

9 (5.1)

 Pancreas

7 (3.9)

 Other GI

6 (3.4)

 Small cell lung cancer

6 (3.4)

 Breast

3 (1.7)

 Kidney

3 (1.7)

 Liver

3 (1.7)

 Prostate

3 (1.7)

  1. aRecent includes smokers who quit within the past 5 years